Authors:
THOMAS LJ
ADARI H
PICARD MD
HONAN CM
MILLER DP
RITTERSHAUS CW
PETTEY CL
Citation: Lj. Thomas et al., USE OF XENOGENEIC CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) IN A PLASMID-BASED VACCINE TO PRODUCE ANTI-CETP AUTOANTIBODIES FOR THE PREVENTION TREATMENT OF ATHEROSCLEROSIS/, The FASEB journal, 12(4), 1998, pp. 1805-1805
Authors:
THOMAS LJ
PICARD MD
STEWART SE
WAITE BCD
LIN AY
RITTERSHAUS CW
PETTEY CL
Citation: Lj. Thomas et al., A PLASMID-BASED VACCINE TO ELICIT AUTOANTIBODIES TO CHOLESTERYL ESTERTRANSFER PROTEIN (CETP) FOR THE PREVENTION TREATMENT OF ATHEROSCLEROSIS/, Journal of allergy and clinical immunology, 99(1), 1997, pp. 754-754
Authors:
PICARD MD
LADISCH S
UMLAUF SW
HASEGAWA A
PETTEY CL
LIN AY
THOMAS LJ
Citation: Md. Picard et al., A CHEMICALLY SYNTHESIZED GANGLIOSIDE ANALOG, GSC-53, INHIBITS ANTIBODY-PRODUCTION AND THE DELAYED-TYPE HYPERSENSITIVITY RESPONSE, The FASEB journal, 10(6), 1996, pp. 376-376
Authors:
THOMAS LJ
AXBERG I
ANDREWS B
WAITE CD
MAKRIDES SC
PETTEY CL
Citation: Lj. Thomas et al., PRODUCTION OF A TRANSGENIC MOUSE EXPRESSING THE HUMAN T-CELL ANTIGEN RECEPTOR V-BETA-5.3 SEGMENT, The FASEB journal, 10(6), 1996, pp. 1025-1025
Authors:
WAITE BCD
FORD PJ
MAKRIDES SC
MARSH HC
PETTEY CL
Citation: Bcd. Waite et al., MEMBRANE EXPRESSION OF COMPLEMENT RECEPTOR-TYPE-1 PERMITS LIMITED GROWTH OF HAMSTER-CELLS IN RATS, The FASEB journal, 9(4), 1995, pp. 807-807